BR100 Increased By (0.91%)
BR30 Increased By (1.03%)
KSE100 Increased By (0.95%)
KSE30 Increased By (1.02%)
AGHA 6.39 Increased By ▲ 0.01 (0.16%)
BECO 4.38 Increased By ▲ 0.03 (0.69%)
BML 62.97 Increased By ▲ 0.42 (0.67%)
BOP 31.44 Increased By ▲ 0.05 (0.16%)
CNERGY 11.77 Increased By ▲ 0.04 (0.34%)
CSIL 5.79 Decreased By ▼ -0.12 (-2.03%)
FCCL 61.82 Increased By ▲ 0.11 (0.18%)
FFL 14.85 Increased By ▲ 0.06 (0.41%)
FNEL 1.30 Increased By ▲ 0.06 (4.84%)
KEL 6.34 Increased By ▲ 0.02 (0.32%)
KOSM 5.82 Decreased By ▼ -0.08 (-1.36%)
LOTCHEM 24.80 Increased By ▲ 0.11 (0.45%)
MLCF 106.14 Increased By ▲ 2.21 (2.13%)
NBP 174.50 Increased By ▲ 1.18 (0.68%)
NCPL 52.50 Increased By ▲ 0.67 (1.29%)
NPL 54.80 Increased By ▲ 0.77 (1.43%)
OGDC 318.80 Increased By ▲ 2.93 (0.93%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 35.85 Increased By ▲ 0.27 (0.76%)
PIBTL 14.21 Increased By ▲ 0.55 (4.03%)
PPL 229.99 Increased By ▲ 3.92 (1.73%)
PRL 81.50 Increased By ▲ 1.22 (1.52%)
PTC 46.84 Increased By ▲ 0.20 (0.43%)
SSGC 24.13 Increased By ▲ 0.31 (1.3%)
TBL 9.32 Increased By ▲ 0.08 (0.87%)
TELE 7.60 Increased By ▲ 0.05 (0.66%)
TPL 24.69 Increased By ▲ 0.15 (0.61%)
TPLP 12.91 Decreased By ▼ -0.08 (-0.62%)
TREET 26.51 Increased By ▲ 0.53 (2.04%)
TRG 53.74 Increased By ▲ 0.41 (0.77%)
World

Philippines approves emergency use of Novavax COVID-19 vaccine

Published Updated
By

MANILA: The Philippines has approved the emergency use of a COVID-19 vaccine by Novavax Inc, its food and drug agency chief said on Wednesday, the ninth vaccine approved in the Southeast Asian country.

The nanoparticle vaccine, under the brand name Covovax, will be manufactured by Serum Institute of India, and is approved for use on adults 18 and above, the agency's chief Rolando Enrique Domingo told a public briefing.

Covovax, which had efficacy of 89.7% in clinical trials, will be administered in two doses not less than 21 days apart, Domingo added.

Japan orders 150 million doses of Novavax Covid vaccine

The Philippines has inoculated more than a quarter of its 110 million population.

Early this month, Novavax received its first emergency use authorisation from Indonesia. Novavax also filed an application for approval of the vaccine in Canada and with the European Medicines Agency.

Comments

Comments are closed for this article.